FDA approves Stanford Medicine-developed drug that treats rare heart disease Stanford Medical Center Report Nawigacja wpisu Stanford Medicine study discovers what’s behind heart cell damage from chemotherapy – Stanford Medical Center Report An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models – Science
